References
Greenwell, H, Bissada, et al. Emerging concepts in periodontal therapy. Drugs 2002; 62 (18): 2581–7.
Offenbacher S, Katz V, Fertik G, et al. Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol 1996; 67 (10): 1103–13.
Bazile A, Bissada N, Nair R, et al. Periodontal assessment of patients undergoing angioplasty for the treatment of coronary artery disease. J Periodontol 2002; 73 (6): 631–6.
Beck J, Garcia R, Heiss G, et al. Periodontal disease and cardiovascular disease. J Periodontol 1996; 67 (10): 1123–37.
Greenwell H, Bissada NF, Dodge JR. Disease masking: a hazard of nonsurgical periodontal therapy. Periodontal Insights 1998; 5 (4): 14–9.
Jones CG. Chlorhexidine: is it still the gold standard? Periodontol 2000 1997; 15: 55–62
Greenstein G, Tonetti M. The role of controlled drug delivery for periodontitis. Position paper: American Academy of Periodontology. J Periodontol 2000; 71 (1): 125–40.
Slots J. Systemic antibiotics in periodontics. Position paper: American Academy of Periodontology. J Periodontol 1996; 67 (8): 831–8.
Matisko M, Bissada NF. Short-term sequential administration of amoxicillin/clavulanate potassium and doxycycline in the treatment of recurrent periodontitis. J Periodontol 1993; 64 (6): 553–8.
Golub LM, McNamara TF, Ryan ME, et al. Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol 2001; 28 (2): 146–56.
Paquette DW, Williams RC. Modulation of host inflammatory mediators as a treatment strategy for periodontal diseases. Periodontol 2000; 24: 239–52
Williams RC, Offenbacher S, Jeffcoat MK, et al. Indomethacin or flurbiprofen treatment of periodontitis in beagles: effect on crevicular fluid arachidonic acid metabolites compared with effect on alveolar bone loss. J Periodontal Res 1988; 23 (2): 134–8.
Williams RC, Jeffcoat MK, Howell TH, et al. Topical flurbiprofen treatment of periodontitis in beagles. J Periodont Res 1988; 23 (3): 166–9.
Paquette DW, Fiorellini JP, Martuscelli H, et al. Enantiospecific inhibition of ligature-induced periodontitis in beagles with topical (S)-ketoprofen. J Clin Periodontol 1997; 24 (8): 521–8.
Jeffcoat MK, Reddy MS. Alveolar bone loss and osteoporosis: evidence for a common mode of therapy using the bisphosphonate alendronate. In: Davidovitch Z, editor. The biologic mechanism of tooth resorption and replacement by implants. Boston: Harvard Society for the Advancement of Orthodontics, 1966: 365–73
Yaffe A, Golomb G, Breuer E, et al. The effect of topical delivery of novel bisacylphosphonates in reducing alveolar bone loss in the rat model. J Periodontol 2000; 71 (10): 1607–12.
Gaffar A, Scherl D, Afflitto J, et al. The effect of triclosan on mediators of gingival inflammation. J Clin Periodontol 1995; 22 (6): 480–4.
Rosling B, Wannfors B, Volpe AR, et al. The use of a triclosan/copolymer dentifrice may retard the progression of periodontitis. J Clin Periodontol 1997; 24 (12): 873–80.
Johnson GK. Tobacco use and the periodontal patient. Position paper: American Academy of Periodontology. J Periodontol 1999; 70 (11): 1419–27.
Rights and permissions
About this article
Cite this article
Adjunctive antibacterial drug therapy useful in recurrent periodontitis. Drugs Ther. Perspect 19, 12–16 (2003). https://doi.org/10.2165/00042310-200319120-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200319120-00005